On a study on early-, middle-, and late-stage liver cirrhosis animal models, STRI demonstrated that nEPS treatment can decreases fibrosis and inflammation. Results were verified by ALT level and histological analyses.
– STRI have studied the elimination of liver tumor with nEPS injection of liver tumor animal models.
Cirrhosis is a condition in which the liver does not function properly due to long-term damage. This damage is characterized by the replacement of normal liver tissue with scar tissue.
It is most commonly caused by alcohol, hepatitis B, hepatitis C, and non-alcoholic fatty liver disease. Cirrhosis has affected about 2.8 million people and resulted in 1.3 million deaths in 2015. Of these, alcohol caused 348,000, hepatitis C caused 326,000, and hepatitis B caused 371,000 deaths.
Liver cirrhosis was induced via TAA injection to the mouse model. Afterward, the nEPS was treated, and as a result, liver tissue was recovered to the normal range.